发明公开
- 专利标题: INTEIN MEDIATED PEPTIDE LIGATION
- 专利标题(中): 内含肽介导肽连接
-
申请号: EP99950063申请日: 1999-09-30
-
公开(公告)号: EP1117693A4公开(公告)日: 2003-06-25
- 发明人: XU MING-QUN , EVANS THOMAS C
- 申请人: NEW ENGLAND BIOLABS INC
- 专利权人: NEW ENGLAND BIOLABS INC
- 当前专利权人: NEW ENGLAND BIOLABS INC
- 优先权: US10241398 1998-09-30
- 主分类号: C12N15/09
- IPC分类号: C12N15/09 ; C07K1/04 ; C07K1/107 ; C07K19/00 ; C12N9/00 ; C12N15/62 ; C12N9/90 ; C12P21/02 ; C12P21/04
摘要:
An in vitro method for producing a semi-synthetic fusion protein is provided, whereby a target protein fused to an intein - a protein splicing element - is selectively cleaved in a first step as depicted in Figure 1 with a thiol reagent, forming a carboxyl-terminal thioester of the target protein and releasing the target protein from the intein. In a subsequent step as shown in Figure 1, a desired, synthetic, protein or peptide having an amino-terminal cysteine is ligated to the target protein. Standard thiol-reagents such as DTT, or thiol-reagents optimized for ligation such as the odorless MESNA, may be used in the first step. The method permits the direct ligation of a desired peptide to a thioester bond that had linked a target protein to an intein. An in vivo variation of the method will permit production of a cytotoxic protein: a truncated, inactive, form of the protein fused to an intein is introduced in vivo, this fusion product is then selectively cleaved, and a synthetic protein or peptide is subsequently ligated at a carboxyl-terminal thioester of the target protein in order to restore the native activity of the cytotoxic protein.
信息查询
IPC分类: